D-Dimer as Predictor of Disease Outcome in Intensive Care Unit in COVID-19m Patients

Evaluating value of D-Dimer blood level of icu admitted patients on admission and 48 hours later as outcome predictor in SARS.COV.2 patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Critical Illness Disease Attributes Infections Lung Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms Pneumonia Pneumonia, Viral Respiratory Tract Diseases Respiratory Tract Infections Virus Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

Ain shams university hospitals, Cairo, Egypt

About this study

Evaluating value of D-Dimer blood level of icu admitted patients on admission and 48 hours later as outcome predictor in SARS.COV.2 patients.

It has been reported that COVID 19 is associated with hemostatic abnormalities and elevated D-Dimer level, so its level is used to predict severity of disease.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

patients of both sex admitted in icu
positive PCR
requiring oxygen therapy

Exclusion criteria

ward patients
negative PCR

Treatment and study plan

no intervention, just observational for D-Dimer level in blood

Other

observation for basal D-Dimer and 48 hours later D-Dimer in blood for ICU SARS.COV.2 patients

Primary outcomes

28 days mortality

Time frame: 1 month

Outcomes of ICU stay

Secondary outcomes

length of stay and mechanical ventilation

Time frame: during ICU stay

time of admission and need to escalate oxygen therapy

Sponsors and collaborators

Lead sponsor

Ain Shams University

Other

Registry information

Official study title

D-Dimer as Predictor of Disease Outcome in Intensive Care Unit in SARS-COV-2 Patients: A Retrospective Study

Acronym: COVID-19

Important dates

Study start: 2021
Primary completion: 2022
Study completion: 2022
First posted: Mar 15, 2022
Registry last updated: Mar 15, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed